Northern Trust
ANRO icon

Northern Trust’s Alto Neuroscience ANRO Stock Holding History

Northern Trust’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Sell
473,403
-970
-0.2% -$18K ﹤0.01% 2037
2025
Q4 		$8.44M Buy
474,373
+13,088
+3% +$165K ﹤0.01% 2173
2025
Q3 		$1.85M Sell
461,285
-2,059
-0.4% -$6.83K ﹤0.01% 3074
2025
Q2 		$1.02M Sell
463,344
-125,935
-21% -$300K ﹤0.01% 3386
2025
Q1 		$1.27M Buy
589,279
+2,144
+0.4% +$7.67K ﹤0.01% 3171
2024
Q4 		$2.48M Buy
587,135
+390,190
+198% +$2.44M ﹤0.01% 2901
2024
Q3 		$2.25M Buy
196,945
+175,911
+836% +$2.15M ﹤0.01% 2928
2024
Q2 		$225K Buy
21,034
+4,647
+28% +$60.5K ﹤0.01% 3829
2024
Q1 		$252K Buy
+16,387
New +$256K ﹤0.01% 3815

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return